Pricing Log in Create free account

InflaRx N.V. (IFRX) vs MacroGenics, Inc. (MGNX)

InflaRx N.V. and MacroGenics, Inc. are both Biotechnology companies. InflaRx N.V. and MacroGenics, Inc. are of similar size ($214.7M and $212.2M). MacroGenics, Inc. grew revenue faster over the last twelve months: 21.9% against −83.4%. InflaRx N.V. has the higher net margin (0.00% vs −7.97%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InflaRx N.V. leads on 9 and MacroGenics, Inc. on 6.

Valuation

Metric IFRX MGNX Biotechnology median
P/E n/m n/m 8.50
P/S 5,075.70 1.13 9.71
P/B 0.91 4.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.71 n/m 0.64
EV/Sales (1,061.22) 0.22 9.21
Earnings yield (43.94%) (6.77%) (33.15%)
Free cash flow yield (17.60%) (31.71%) (25.50%)

Profitability

Metric IFRX MGNX Biotechnology median
Gross margin (26,762.42%) 78.07% 65.16%
Operating margin 0.00% (18.73%) 0.00%
Net margin 0.00% (7.97%) 0.00%
Free cash flow margin 0.00% (35.80%) 0.00%
Return on equity (38.71%) (32.61%) (56.36%)
Return on assets (32.75%) (4.94%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IFRX MGNX Biotechnology median
Revenue growth (TTM) (83.39%) 21.93% 6.02%
EPS growth (last fiscal year) 9.41% (10.28%) 30.26%
Revenue growth, 5-year CAGR — 7.35% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IFRX MGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.22 2.96 4.72
Net debt to EBITDA 0.97 2.82 0.96

Dividend

Metric IFRX MGNX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IFRX MGNX Biotechnology median
Market cap 212.21m 214.67m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack